CD8A and neoplasm: Interestingly, the tumour antigen–specific CD8+ T cells identified by tetramer staining in responder patients were often of a differentiated effector cell phenotype compared with antigen‐specific CD8+ T cells from patients with progressive disease that displayed a more memory‐like phenotype.61